Youn H. Kim is the Joanne and Peter Haas Jr. Professor for Cutaneous Lymphoma Research at Stanford University School of Medicine and the Stanford Cancer Institute. Dr. Kim serves as the Director of the Multidisciplinary Cutaneous Lymphoma Clinic and Research Program and is a member of the T-cell Lymphoma/Cutaneous Lymphoma Panel of the National Comprehensive Cancer Network (NCCN). She serves on the Board of Directors of the International Society for Cutaneous Lymphomas (ISCL) and is a past President of the ISCL. Dr. Kim also serves on the Board of Directors of the U.S. Cutaneous Lymphoma Consortium (USCLC) and is the co-founder and global co-leader of the Cutaneous Lymphoma International Consortium (CLIC).
Dr. Kim has published extensively to advance the field of cutaneous lymphoma. Stanford houses one of the largest single-center longitudinal databases in mycosis fungoides (MF) and Sézary syndrome (SS). Stanford’s Multidisciplinary Cutaneous Lymphoma Clinic is a major national and international referral center, offering access to key clinical trials, advanced diagnostic tools, and cutting-edge molecular profiling methods to optimize personalized therapy in cutaneous lymphoma. Dr. Kim has served as principal investigator or co-investigator in multiple pivotal clinical trials that have been critical in the discovery, development, and approval of newer therapies in cutaneous T-cell lymphoma.
🏥 University Affiliation, City, Country: Stanford University, Stanford, California, USA
🧪 Area of focus in clinical practice and research: Her clinical research has focused in 3 key areas: (1) clinical outcome studies in patients with cutaneous lymphoma, (2) therapeutic trials (industry and investigator-initiated) and translational research involving new therapy development in cutaneous lymphoma, and (3) furthering our understanding of molecular and immunologic pathogenesis and biomarkers reflective of prognosis and response to therapy.